$SION
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
Healthcare
Sector
Biotechnology
Industry
Michael Cloonan
CEO
41
Employees
$6.00
Current Price
$1.84B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 2 | $21,835,017.52 | 3,448,811 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 2 | $21,835,017.52 | 3,448,811 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 2 | $21,835,017.52 | 3,448,811 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 3,415,011 | $6.32 | $21,582,869.52 | View Details |
| Sep 17, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 33,800 | $7.46 | $252,148.00 | View Details |
135 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.64
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies:
$TRAW โ Traws Pharma, Inc.via ORBIMED ADVISORS LLC$CDTX โ Cidara Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.$WVE โ Wave Life Sciences, Inc.via RA CAPITAL MANAGEMENT, L.P.$PBLS โ Parabilis Medicines, Inc.via RA CAPITAL MANAGEMENT, L.P.$QTTB โ Q32 Bio Inc.via ORBIMED ADVISORS LLC$PRLD โ Prelude Therapeutics Incvia ORBIMED ADVISORS LLC$STTK โ Shattuck Labs, Inc.via ORBIMED ADVISORS LLC$EWTX โ Edgewise Therapeutics, Inc.via Thompson Peter A.$ACET โ Adicet Bio, Inc.via RA CAPITAL MANAGEMENT, L.P.$CLYM โ Climb Bio, Inc.via RA CAPITAL MANAGEMENT, L.P.